Depression
Tonix Pharmaceuticals Abandons Depression Drug Post-Phase 2 Failure
Tonix Pharmaceuticals has experienced a setback in its pipeline as it discontinues the development of a major depression disorder (MDD) ...
Relmada reports positive results from open-label trial of REL-1017 for major depressive disorder
Relmada Therapeutics, a central-nervous-system-focused biotech company, has finally glimpsed a ray of optimism after facing setbacks in two phase 3 ...
Juli App: A Revolutionary AI Solution for Asthma and Depression
Juli, an AI-driven platform designed to aid individuals in managing chronic health conditions, has demonstrated significant improvements in two separate ...
Intra-Cellular Therapies Elevates Caplyta’s Impact with ‘Let in the Lyte’ Campaign
In a strategic move fueled by its triumph in the Fierce Madness Drug Ad Tournament, Intra-Cellular Therapies is significantly enhancing ...
Big Health Acquires Limbix, a DTx Developer for Teen Depression
Source – Big Health In a move to further consolidate its position in the digital therapeutics (DTx) sector, Big Health ...
New Study Demonstrates Psilocybin as Affordable and Effective Treatment for Major Depression
Research conducted by Clerkenwell Health and the University of Greenwich suggests that psilocybin, a psychedelic compound found in certain mushrooms, ...
